Melior is Proud to Recognize Client Success

At Melior, we recognize the requirement of product value generation towards raising additional capital or achieving an exit.  We further understand that until clinical proof-of-concept data is generated, in vivo model data is usually the most important value-add that a product receives.  We carefully approach every study that we conduct for clients with this in mind, and we are thrilled (vicariously) when we see our clients achieve great success, especially in the event that the data we provided played a pivotal part.

The number of our studies that have been submitted to INDs, or contributed to pitch decks that got funded, is too numerous and hard-to-track here.  Therefore, over the last ten years, we have begun to assemble a sort of “best of” list comprised of companies whom we have provided data to that were subsequently purchased by a larger company.  In all cases, the acquisitions came within a year or two of the studies that we completed for that client and we are delighted if our contribution was an important part of the story.

While all the credit for these deals undoubtedly goes to the ingenuity and hard work of these management teams; we are nonetheless so proud to be part of the value generation from these multiple exits.

Let Melior help you extract the full value opportunity from your product.